Monthly Features

Is there really a shortage of study volunteers?

Saturday, August 1, 2015

Patient recruitment remains one of the biggest challenges facing the clinical research enterprise today. Forward-thinking industry leaders recognize the need for rethinking the common view that pa­tient recruitment is difficult primarily due to a shortage of study volunteers. Instead, these experts believe the industry needs to focus the discussion on practices that limit access to clinical trials and how to build support sys­tems needed to better engage patient commu­nities and the public in clinical research.

[Read More]

Pharma industry improves its tarnished reputation

Monday, June 15, 2015

The reputation of the pharmaceutical industry—historically not much better than that of the oil or tobacco industries—has stabilized in recent years. And public views about clinical research have improved significantly. Yet overall, the level of trust in pharmaceutical companies remains low.

[Read More]

TransCelerate Biopharma turns three

Monday, June 1, 2015

The name alone excites many in clinical research. It’s the first—or so far best promoted—consortium consisting only of high-level people from big biopharmaceutical companies, each vowing to be deeply “pre-competitive” with one another while trying to rework some of the redundant and wasteful practices endemic to clinical research.

[Read More]

Job satisfaction mixed as workload increases

Friday, May 1, 2015

Since the recession ended six years ago, clinical research professionals have become more optimistic about the economic outlook of their companies. Yet job satisfaction levels are mixed—the workforce has seen its workload and responsibilities rise dramatically, while mean salary levels have increased only slightly when adjusted for inflation.

[Read More]

PSI, INC Research, Chiltern best with sites

Wednesday, April 1, 2015

Contract research organizations (CROs) have become more effective in managing working relationships with investigative sites during the past two years, according to a new CenterWatch survey, yet the average CRO continues to fall below performance expectations in many of the areas investigators consider most critical for study success.

[Read More]

Novo Nordisk, Takeda, Servier, Celgene among top sponsors

Sunday, March 1, 2015

Relationships between drug sponsors and investigative sites have become more effective during the past two years, according to a new CenterWatch survey, as the initiatives top sponsors have implemented in recent years to address site burdens—such as increased protocol complexity and insufficient study support—are beginning to have a positive impact.

[Read More]

Study grants market breaks $13 billion

Sunday, February 1, 2015

A new CenterWatch analysis of the global clinical trial grants market, a critical measure of the overall health of the enterprise, reveals a mixed message: Industry-sponsored clinical trial activity has increased compared to a decade ago, yet growth in grant spending to investigative sites from both the government and industry has continued to slow significantly. [Read More]